Recruiting
Phase 1

Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy

Sponsor:

Mayo Clinic

Code:

NCT05789394

Conditions

Recurrent Glioblastoma, IDH-Wildtype

Recurrent Astrocytoma, IDH-Mutant, Grade 4

Astrocytoma, Grade IV

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Allogeneic Adipose-derived Mesenchymal Stem Cells

Biospecimen Collection

Craniotomy

Magnetic Resonance Imaging

Ommaya Reservoir Tap

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information